Tachykinins in the respiratory tract

Area of Science:

• Respiratory Medicine
• Neuroimmunology
• Pharmacology

Background:

• Tachykinins (e.g., substance P, neurokinin A) are peptides released from airway nerves and other cells.
• They regulate airway smooth muscle, vascular tone, mucus secretion, and immune responses.
• Tachykinins play a role in inflammatory airway diseases like asthma and COPD.

Purpose of the Study:

• To review the role of tachykinins in respiratory functions and diseases.
• To explore the therapeutic potential of tachykinin receptor antagonists.
• To introduce newly discovered tachykinin peptides and their potential respiratory functions.

Main Methods:

• Literature review of tachykinin research in respiratory contexts.
• Analysis of the physiological and pathological roles of tachykinins.
• Discussion of current and emerging therapeutic targets, including receptor antagonists.

Main Results:

• Tachykinins significantly influence respiratory functions and are involved in airway inflammation.
• Dual tachykinin (NK1 and NK2) receptor antagonists show bronchoprotective effects.
• New tachykinin peptides (hemokinin 1, endokinins A/B) have been identified, requiring further study.

Conclusions:

• Tachykinins are crucial mediators in respiratory health and disease.
• Targeting tachykinin receptors, particularly NK1 and NK2, presents a promising therapeutic avenue for airway diseases.
• Further research is needed to elucidate the roles of novel tachykinin peptides in the respiratory system.